Rate and pattern of antibiotic resistance in microbiological cultures of sepsis patients in a low-middle-income country's ICU

Middle East Journal of Anesthesiology

Volumn 22, Issue 3, 2013, Pages 293-300

  Bataar, Otgon ^a   Khuderchuluun, Chuluunchimeg ^a   Lundeg, Ganbold ^a   Chimeddorj, Sukhjargalan ^a   Brunauer, Andreas ^b   Gradwohl Matis, Ilse ^b   Duenser, Martin W ^b  

^a Central State University Hospital   (Mongolia)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTEREMIA; CONFERENCE PAPER; CRITICAL ILLNESS; DEVELOPING COUNTRY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTIDRUG RESISTANCE; PROSPECTIVE STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CRITICAL ILLNESS; DEVELOPING COUNTRIES; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84893231729     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. J awad I, Luksic I, Rafnsson SB: Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J. Glob. Health; 2012, 2:10404.
2. D ünser MW, Festic E, Dondorp A, Kissoon N, Ganbat T, Kwizera A, Haniffa R, Baker T, Schultz MJ: GLOBAL INTENSIVE CARE WORKING GROUP OF EUROPEAN SOCIETY OF INTENSIVE CARE MEDICINE: Recommendations for sepsis management in resource-limited settings. Intensive Care Med; 2012, 38:557-574.
3. K umar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med; 2006, 34:1589-1596.
4. N iedermann MS: Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit. Care Med; 2001, 29(4 Suppl):N114-120.
5. B yarugaba DK: A view on antimicrobial resistance in developing countries and responsible risk factors. Int. J. Antimicrob. Agents; 2004, 24:105-110.
6. M ccabe WR, Jackson GG: Gram-negative baceremial. Etiology and ecology. Arch. Intern. Med; 1962, 110:847-891.
7. L e Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA; 1993, 270:2957-2963.
8. L evy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med; 2003, 31:1250-1256.
9. M agiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Lijequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL: Multidrug-resistant, extensively durg- resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect; 2012, 18:268-281.
10. th informational supplement. CLSI document M100-S17. CLSI, Wayne, PA, 2007.
11. Zhanel GG, Decorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, Nichol KA, Wierzbowski A, Baudry PJ, Kariowsky JA, Lagacé-Wiens P, Walkty A, Mccracken M, Mulvey MR, Johnson J: CANADIAN ANTIMICROBIAL RESISTANCE ALLIANCE (CARA), HOBAN DJ: Antimicrobial-resistant pathogens in intensive care units in Canada (CAN-ICU) study, 2005-2006. Antimicrob. Agents Chemother; 2008, 52:1430-1470.
12. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY, Leblebicioglu H, Abu Khader I, Miranda Novales MG, Berba R, Ramirez Wong FM, Barkat A, Pino OR, Duenas L, Mitrev Z, Bije H, Gurskis V, Kanj SS, Mapp T, Hidalgo RF, Ben Jaballah N, Raka L, Gikas A, Ahmed A, Thu Le TA, Guzman Siritt ME: INICC MEMBERS: International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am. J. Infect. Control; 2010, 38:95-104.e2.
13. Saied T, Elholy A, Hafez SF, Basim H, Wasfy MO, El-Shoubary W, Samir A, Pimentel G, Talaat M: Antimicrobial resistance in pathogens causing nosocomial bloodstream infections in university hospitals in Egypt. Am. J. Infect. Control; 2010, 39:e61-65.
14. Rocha LDE A, Vilela CA, Cezario RC, Almeida AB, Gontijo Filho P: Ventilator-associated pneumonia in an adult clinical surgical intensive care unit of a Brazilian university hospital: incidence, risk factors, etiology, and antibiotic resistance. Braz. J. Infect. Dis; 2008, 12:80-85.
15. Inan A, Ozgultekin A, Akcay SS, Engin DO, Turan G, Ceran N, Dincer E, Aksaray S, Goktas P, Erdem I: Alterations in bacterial spectrum and increasing resistance rates in isolated microorganisms from device-associated infections in an intensive care unit of a teaching hospital in Istanbul (2004-2010). Jpn. J. Infect. Dis; 2012, 65:146-151.
16. Haeili M, Ghodousi A, Nomanpour B, Omrani M, Feiabadi MM: Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011. J. Infect. Dev. Ctries; 2013, 7:312-317.
17. Diouf E, Beye MD, Diop Ndoye M, Kane O, Seydi AA, Ndiaye PI, Bah MD, Sall KB: Nosocomial ventilator-associated pneumonia in a tropical intensive care unit. Dakar. Med; 2006, 51:81-88.
18. Xu J, Sun Z, Li Y, Zhou Q: Surveillance and correlation of antibiotic consumption and resistance of Acinetobacter baumannii complex in a tertiary care hospital in northeast China, 2003-2011. Int. J. Environ. Res. Public. Health; 2013, 10:1462-1473.
19. Durante-Mangoni E, Zarrilli R: Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol; 2011, 6:407-422.
20. Keen EF 3rd, Murray CK, Robinson BJ, Hospenthal DR, Co EM, Aldous WK: Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center. Infect. Control. Hosp. Epidemiol; 2010, 31:728-732.
21. Ahmed SH, Daef EA, Badary MS, Mahmoud MA, Abd-Elsayed AA: Nosocomial blood stream infection in intensive care units at Assiut University Hospital (Upper Egypt) with special reference to extended spectrum beta-lactamase producing organisms. BMC. Res. Notes; 2009, 2:76.
22. Kanafani ZA, Kara L, Hayek S, Kanj SS: Ventilator-associated pneumonia at a tertiary-care center in a developing country: incidence, microbiology, and susceptibility patterns of isolated microorangisms. Infect. Control. Hosp. Epidemiol; 2003, 24:864-869.
23. Thamlikitkul V: Antibiotic dispensing by drug store personnel in Bangkok, Thailand. J. Antimicrob. Chemother; 1998, 21:125-131.
24. Togoobaatar G, Ikeda N, Ali M, Sonomjamts M, Dashdemberel S, Mori R, Shibuya K: Survey of non-prescribed use of antibiotics for children in an urban community in Mongolia. Bull. World Health. Organ; 2010, 88:930-936.
25. Allegranzi B, Sax H, Bengaly L, Richet H, Minta DK, Chraiti M N, Sokona FM, Gayet-Ageron A, Bonnabry P, Pittet D: WORLD HEALTH ORGANIZATION "POINT G" PROJECT MANAGEMENT COMMITTEE: Successful implementation of the World Health Organization hand hygiene improvement strategy in a referral hospital in Mali, Africa. Infect. Control. Hosp. Epidemiology; 2010, 31:133-141.
26. Pittet D, Allegranzi B, Storr J, Bagheri Nejad S, Bziekan G, Leotsakos A, Donaldison L: Infection control as a major World Health Organization priority for developing countries. J. Hosp. Infect; 2008, 68:285-292.
27. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest; 2000, 118:146-155.
28. Zahar JR, Timsit JF, Garrouste-Orgeas M, Francais A, Vesin A, Descorps-Declere A, Dubois Y, Souweine B, Haouache H, Goldgran-Toledano D, Allaouchiche B, Azoulay E, Adrie C: Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit. Care Med; 2011; 39:1886-1895.
29. Sostarich AM, Zolldann D, Haefner H, Luetticken R, Schulze- Roebecke R, Lemmen SW: Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay. Infection; 2008, 36:31-35.
30. Cortés JA, Garzón DC, Navarrete JA, Contreras KM: Impact of inappropriate antimicrobial therapy on patients with bacteremia in intensive care units and resistance patterns in Latin America. Rev. Argent. Microbiol; 2010, 42:230-234.
31. Bataar O, Lundeg G, Tsenddorj G, Jochberger S, Grander W, Baelani I, Wilson I, Baker T, Dünser MW: HELFEN BERÜHRT STUDY TEAM: Nationwide survey on resource availability for implementing current sepsis guidelines in Mongolia. Bull. World Health. Organ; 2010, 88:839-846.
32. Baelani I, Jochberger S, Laimer T, Otieno D, Kabutu J, Wilson I, Baker T, Dünser MW: Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: a self-reported, continent-wide survey of anaesthesia providers. Crit. Care; 2011, 15:R10.